UTAH MEDICAL PRODUCTS INC (UTMD) › Shareholders' EquityUTAH MEDICAL PRODUCTS INC (UTMD) — Shareholders' EquityAnnual figures by period end, from SEC filings.2010-12-31: $37.79M2011-12-31: $40.76M2012-12-31: $50.97M2013-12-31: $60.58M2014-12-31: $64.56M2015-12-31: $69.65M2016-12-31: $69.24M2017-12-31: $78.12M2018-12-31: $88.99M2019-12-31: $101.09M2020-12-31: $102.82M2021-12-31: $107.14M2022-12-31: $114.25M2023-12-31: $128.31M2024-12-31: $117.43M2025-12-31: $119.27M$119.27M2010-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$119.27M+1.6%2026-03-27Balance as of period end2024-12-31$117.43M-8.5%2026-03-27Balance as of period end2023-12-31$128.31M+12.3%2025-03-26Balance as of period end2022-12-31$114.25M+6.6%2024-03-26Balance as of period end2021-12-31$107.14M+4.2%2023-03-28Balance as of period end2020-12-31$102.82M+1.7%2022-03-25Balance as of period end2019-12-31$101.09M+13.6%2021-03-26Balance as of period end2018-12-31$88.99M+13.9%2020-03-16Balance as of period end2017-12-31$78.12M+12.8%2019-03-14Balance as of period end2016-12-31$69.24M-0.6%2018-03-06Balance as of period end2015-12-31$69.65M+7.9%2018-03-06Balance as of period end2014-12-31$64.56M+6.6%2018-03-06Balance as of period end2013-12-31$60.58M+18.9%2017-03-08Balance as of period end2012-12-31$50.97M+25.1%2016-03-10Balance as of period end2011-12-31$40.76M+7.8%2015-03-12Balance as of period end2010-12-31$37.79M—2014-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)